![St. John Morgan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Dale Tomrdle | M | - |
Gid Bio Inc.
![]() Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | - |
William W. Cimino | M | - |
Gid Bio Inc.
![]() Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | - |
Adam J. Katz | M | - |
Gid Bio Inc.
![]() Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | 14 Jahre |
J. William Futrell | M | - |
Gid Bio Inc.
![]() Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | 14 Jahre |
Roy J. Bostock | M | 83 |
Gid Bio Inc.
![]() Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | - |
Nicholas M. Pachuda | M | - |
Gid Bio Inc.
![]() Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | - |
John Marous | M | - |
Gid Bio Inc.
![]() Gid Bio Inc. Medical/Nursing ServicesHealth Services Gid Bio Inc. develops next-generation cellular therapies for degenerative musculoskeletal, dermal, and organ specific diseases. The company is based in Louisville, CO. The technology uniquely isolates and concentrates a cellular implant that is administered by injection in a physician's office under image guidance. The company has been granted two CPT Class III codes, a step toward Medicare reimbursement. Gid Bio's SVF-2 technology and point-of-care therapy harness the innate power of a patient's own stromal cells. The company was founded in 2010 by Adam J. Katz, G. Patrick Maxwell, Ramon Llull, J. William Futrell. The CEO is William W. Cimino. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 7 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- St. John Morgan
- Persönliches Netzwerk